Press Releases

Featured Press Releases

Virginia Governor Glenn Youngkin named BIO’s…

WASHINGTON, DC (September 17, 2024) – Today, the Biotechnology Innovation Organization (BIO) awarded Virginia Governor Glenn Youngkin with its 2024 Governor of the Year Award. BIO’s annual award honors governors for their leadership and…

Learn more

New Season of “I am BIO” Podcast Explores Patient…

WASHINGTON - (September 5, 2024) –The Biotechnology Innovation Organization (BIO) will launch the fall season of the award-winning “I am BIO” podcast on September 10. Now entering its fifth year, the podcast explores the intersection of…

Learn more

BIO Statement On Selected Drugs in Medicare under…

The Biotechnology Innovation Organization (BIO) released the following statement after today’s announcement from the Centers for Medicare & Medicaid Services (CMS) on selected drugs under the Inflation Reduction Act (IRA):“While the Inflation…

Learn more

BIO Applauds Creation of FDA Opioid Policy Steering Committee

May 24, 2017

Washington, DC (May 24, 2017) – Biotechnology Innovation Organization (BIO) President and CEO Jim Greenwood issued the following statement regarding the announced creation of an Opioid Policy Steering Committee at the Food and Drug…

Astellas Expands Advocacy Engagement with Focused Outreach

May 23, 2017

Astellas recognizes the crucial role that patient groups play in enhancing and extending the lives of patients. Sponsoring events such as the BIO Patient and Health Advocacy Summit to be held on November 3-4 is a way the Astellas…

BIO Statement on President’s Proposed 2018 Budget

May 23, 2017

Biotechnology Innovation Organization (BIO) President and CEO Jim Greenwood issued the following statement in response to President Trump’s FY 2018 budget proposal.

Biotech Industry Continues Strong Growth in 2016; San Diego Setting Pace for State, Nation

May 17, 2017

Mayor Faulconer, Industry Leaders Reveal Latest Data, Including Major Economic Benefits of June BIO 2017 Convention

BIO Joins Diverse Coalition Promoting Market-Based Solutions to Address Prescription Drug Costs, Increase Patient Access and Choice

May 17, 2017

Washington, DC (May 17, 2017) – Today, the Biotechnology Innovation Organization (BIO) joins with a diverse coalition of stakeholders in endorsing a set of pro-competition, free-market-oriented solutions to lower healthcare costs while…

BIO Submits Comments to EPA Regulatory Reform Task Force

May 16, 2017

BIO submitted comments to the Environmental Protection Agency’s Regulatory Reform Task Force on Executive Order 13777 “Enforcing the Regulatory Reform Agenda.”

BIO Statement on the Passing of Biotechnology Giant Henri Termeer

May 15, 2017

Termeer was a key architect in the founding of BIO, a mentor to countless entrepreneurs, executives and researchers, and passionate in his pursuit of innovative patient-centric drug development. Washington, DC (May 15, 2017) – Henri…

BIO Statement on U.S.-China Comprehensive Economic Dialogue

May 12, 2017

Washington, D.C. (May 12, 2017) – The Biotechnology Innovation Organization (BIO) issued the following statement regarding initial results of the 100-Day Action Plan of the U.S.-China Comprehensive Economic Dialogue:

Convention Programming to Feature “One Health” Concept

May 11, 2017

Bio-based Technologies Address Human, Animal, Plant and Environmental Health Washington, D.C. (May 11, 2017) – At its heart, the concept of One Health is rooted in the notion that the health of humans, animals, and the environment are all…

Ann Romney to Deliver Keynote at 2017 BIO International Convention

May 10, 2017

Former First Lady of Massachusetts and New York Times best-selling author will speak about the power of resilience in overcoming obstacles, advocating for families and spearheading brain health research

Daily News You Can’t Afford to Miss

Read it in under 3 minutes!

The Good Day BIO newsletter is the only daily newsletter at the intersection of biotech, politics, and policy.